Cargando…

Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review)

Duchenne muscular dystrophy (DMD) is the most common degenerative neuromuscular disease. The incidence of DMD in live births is 1/3,600-1/6,000. Although glucocorticoid-dependent medication is the mainstay treatment option for DMD, a standard treatment regimen has yet to be determined. The present r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tianyuan, Kong, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967797/
https://www.ncbi.nlm.nih.gov/pubmed/33777191
http://dx.doi.org/10.3892/etm.2021.9875